Patients with irritable bowel syndrome (IBS) have a significantly greater prevalence of early adverse life events , including general trauma as well as physical, emotional and sexual abuse.

SAN DIEGO, June 16, 2011 /PRNewswire/ -- Tioga Pharmaceuticals, Inc.

SAN DIEGO, June 1, 2011 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that its investigational compound asimadoline has been granted Fast Track designation by the U.S.

From constipation and diarrhea to bloating and abdominal pain, the estimated 30 million victims of irritable bowel syndrome in the United States have it tough.

BURLINGTON, Mass., Dec.